Wed, 28 Nov 2018 07:54:08 GMT
Roche acquires Jecure in chase for liver disease treatment
Swiss drugmaker Roche signed a deal to acquire the US biotech firm Jecure Therapeutics, joining Novartis, Gilead Sciences and Pfizer in a race for new drugs to cure fatty liver disease.